Biotech & Health Tech
BioNTech pays $205M for Scholar Rock voucher; J&J pulls back in Norway
Plus, news about Vor Bio, RemeGen, Merck KGaA, Aidea, Astellas and Immuneering. BioNTech acquires PRV for $205 million: The German biotech scooped up the FDA voucher from Scholar Rock, with plans ...
Plus, news about Vor Bio, RemeGen, Merck KGaA, Aidea, Astellas and Immuneering. BioNTech acquires PRV for $205 million: The German biotech scooped up the FDA voucher from Scholar Rock, with plans ...
This is a summary of the story. Read the full article at Endpoints News (Biopharma) ↗